Patient‐reported outcomes following treatment with the human GLP‐1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism